PO-1353: Validation of a commercial software for in vivo patient Quality Assurance

2020 ◽  
Vol 152 ◽  
pp. S717
Author(s):  
C. Talamonti ◽  
L. Marrazzo ◽  
S. Russo ◽  
E. Vanzi ◽  
C. Arilli ◽  
...  
2015 ◽  
Vol 115 ◽  
pp. S762-S763
Author(s):  
L. Reversi ◽  
C. Talamonti ◽  
E. Vanzi ◽  
G. Giani ◽  
M. Casati ◽  
...  

2007 ◽  
Vol 67 (1) ◽  
pp. 288-295 ◽  
Author(s):  
Hansjoerg Wertz ◽  
Judit Boda-Heggemann ◽  
Cornelia Walter ◽  
Barbara Dobler ◽  
Sabine Mai ◽  
...  

2016 ◽  
Author(s):  
◽  
Jason Stanford

[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Advance treatment techniques, such as IMRT and dynamic conformal arc delivery, are novel radiation treatment procedures at the forefront of accurate and precise radiotherapy. However, the risk of suboptimal treatment resulting in injury is far greater with these techniques due to their complexity. An in vivo quality assurance system is the most appropriate validation of the delivered dose to the patient from these techniques. The intent of this research is to propose an in vivo dosimetry quality assurance procedure using radiochromic film. This research proved that radiochromic in vivo dosimetry is a viable method of detecting spatial patient specific errors in radiotherapy; however, the process is time consuming and not sensitive enough for dosimetric errors associated with weight change. Although time consuming, in vivo radiochromic dosimetry is an attractive alternative for small cancer centers and developing countries without the large startup capital to acquire the electronic portal imaging device necessary for EPID in vivo dosimetry.


2012 ◽  
Vol 103 ◽  
pp. S133-S134
Author(s):  
M.R. van den Bosch ◽  
M. van Vulpen ◽  
J.J.W. Lagendijk ◽  
M.A. Moerland

2017 ◽  
Vol 44 ◽  
pp. 205-211 ◽  
Author(s):  
Takeshi Kamomae ◽  
Hidetoshi Shimizu ◽  
Takayoshi Nakaya ◽  
Kuniyasu Okudaira ◽  
Takahiro Aoyama ◽  
...  

1998 ◽  
Vol 71 (846) ◽  
pp. 661-668 ◽  
Author(s):  
C J Millwater ◽  
A S MacLeod ◽  
D I Thwaites
Keyword(s):  

1999 ◽  
Vol 1 (2) ◽  
pp. 73-82
Author(s):  
Robert Appleyard

A clear rationale exists for routine in vivo dosimetry as part of an overall quality assurance (QA) programme within a radiotherapy department. A survey was undertaken in order to identify the extent of diode dosimetry practice within the UK.Questionnaires were distributed to 57 radiotherapy physics departments in the UK in order to determine the extent of central axis diode dosimetry and the protocols implemented, the range of other in vivo measurements performed using diodes and the type of equipment used. Fifty-four responses were received. Eighteen departments undertook some form of central axis entrance dosimetry. Fifteen departments could be considered to be doing this routinely. Seven departments indicated planned future use. Six centres routinely undertook exit dosimetry with a further 3 indicating planned future use. Varied protocols for use were reported by those centres undertaking central axis dosimetry. Thirty-two respondents used a diode system for other forms of in vivo measurements with critical organ and TBI dosimetry being the most common. The vast majority used Scanditronix equipment.Despite the distinct benefits of central axis diode dosimetry, this continues to be infrequently adopted as part of a departmental QA programme. However, an indication of a number of departments planning to implement such an approach is reassuring.


Sign in / Sign up

Export Citation Format

Share Document